NCT00880061 2018-07-05An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade GliomaNational Institutes of Health Clinical Center (CC)Phase 1 Terminated7 enrolled